miR‑515‑5p inhibits the proliferation, migration and invasion of human breast cancer cells by targeting CBX4

Wen,Liu-Jing; Wang,Yue-Sheng; Tan,Pei-Yi

doi:10.3892/etm.2021.10763

miR‑515‑5p inhibits the proliferation, migration and invasion of human breast cancer cells by targeting CBX4

Authors:
- Liu-Jing Wen
- Yue-Sheng Wang
- Pei-Yi Tan
View Affiliations

Affiliations: Department of Pharmacy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, P.R. China, Department of Dentistry, Second Hospital Affiliated to Tianjin Medical University, Tianjin 300211, P.R. China, Department of Pharmacy, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300193, P.R. China
Published online on: September 20, 2021 https://doi.org/10.3892/etm.2021.10763
Article Number: 1328
Copyright: © Wen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

microRNA (miR)‑515‑5p has been previously suggested to function as a tumor suppressor in various types of human cancer. Therefore, the role of miR‑515‑5p in breast cancer (BC) was explored in the present study. A series of assays were performed to study the function of miR‑515‑p in BC cells, including Cell Counting Kit‑8, TUNEL, flow cytometric and colony formation to detect cell viability and apoptosis, wound healing and Transwell assays to measure cell motility. In addition, reverse transcription quantitative PCR and western blot analysis were used to assess miR‑515‑5p, CBX4, Cox‑2, MMP2, MMP9, CDK2, p21 and Cyclin D1 respectively. Bioinformatics and dual‑luciferase reporter assays were used to analyze the target genes of miR‑515‑5p, which confirmed the direct binding between miR‑515‑5p and polycomb chromobox 4 (CBX4). It was found that the expression of miR‑515‑5p is lower in BC cells compared with that in normal breast cells (MCF10A). Overexpression of miR‑515‑5p using the miR‑515 mimic was found to reduce cell viability, facilitate cell apoptosis, inhibit cell proliferation and arrest cell cycle progressio at G₁ phase. In addition, miR‑515‑5p overexpression could inhibit cell migration and invasion, whilst decreasing the expression levels of prostaglandin‑endoperoxide synthase 2, MMP2 and MMP9 proteins. In addition, miR‑515‑5p overexpression could reduce the expression levels of CBX4 in MCF7 and ZR‑75‑30 cells. By contrast, overexpression of CBX4 reversed the effects of the miR‑515‑5p mimic transfection on cell proliferation, migration and invasion in MCF7 and ZR‑75‑30 cells. In combination, these results suggest that miR‑515‑5p inhibits BC cell proliferation, migration and invasion by directly targeting CBX4.

View Figures

View References

1	DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A and Siegel RL: Breast cancer statistics, 2019. CA Cancer J Clin. 69:438–451. 2019.PubMed/NCBI View Article : Google Scholar
2	Zhang ML, Peng P, Wu CX, Gong YM, Zhang SW, Chen WQ and Bao PP: Report of breast cancer incidence and mortality in China registry regions, 2008-2012. Zhonghua Zhong Liu Za Zhi. 41:315–320. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
3	Wu H, Wang Q, Zhong H, Li L, Zhang Q, Huang Q and Yu Z: Differentially expressed microRNAs in exosomes of patients with breast cancer revealed by next-generation sequencing. Oncol Rep. 43:240–250. 2020.PubMed/NCBI View Article : Google Scholar
4	Rossing M, Sørensen CS, Ejlertsen B and Nielsen FC: Whole genome sequencing of breast cancer. APMIS. 127:303–315. 2019.PubMed/NCBI View Article : Google Scholar
5	Lytle JR, Yario TA and Steitz JA: Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci USA. 104:9667–9672. 2007.PubMed/NCBI View Article : Google Scholar
6	Ma C, Miao C, Wang C, Song F and Luo M: PELP1 is a novel oncogene in gastric tumorigenesis and negatively regulated by miR-15 family microRNAs. Cancer Biomark. 26:1–9. 2019.PubMed/NCBI View Article : Google Scholar
7	Zhang C, Liu J, Tan C, Yue X, Zhao Y, Peng J, Wang X, Laddha SV, Chan CS, Zheng S, et al: microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis. Oncotarget. 7:8783–8796. 2016.PubMed/NCBI View Article : Google Scholar
8	Kim S, Lee E, Jung J, Lee JW, Kim HJ, Kim J, Yoo HJ, Lee HJ, Chae SY, Jeon SM, et al: microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer. Oncogene. 37:2982–2991. 2018.PubMed/NCBI View Article : Google Scholar
9	Shao B, Wang X, Zhang L, Li D, Liu X, Song G, Cao H, Zhu J and Li H: Plasma microRNAs predict chemoresistance in patients with metastatic breast cancer. Technol Cancer Res Treat. 18(1533033819828709)2019.PubMed/NCBI View Article : Google Scholar
10	Hromadníková I, Kotlabová K, Jirásek JE and Doucha J: Detection of placenta-specific microRNAs in maternal circulation. Ceska Gynekol. 75:252–256. 2010.PubMed/NCBI(In Czech).
11	Zheng J, Sadot E, Vigidal JA, Klimstra DS, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR and Ventura A: Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing. PLoS One. 13(e0200776)2018.PubMed/NCBI View Article : Google Scholar
12	Zhang X, Zhou J, Xue D, Li Z, Liu Y and Dong L: MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer. Int J Biol Macromol. 129:227–232. 2019.PubMed/NCBI View Article : Google Scholar
13	Li J, Tang Z, Wang H, Wu W, Zhou F, Ke H, Lu W, Zhang S, Zhang Y, Yang S, et al: CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p. Biomed Pharmacother. 97:1182–1188. 2018.PubMed/NCBI View Article : Google Scholar
14	Chen Y, Du J, Wang Y, Shi H, Jiang Q, Wang Y, Zhang H, Wei Y, Xue W, Pu Z, et al: MicroRNA-497-5p induces cell cycle arrest of cervical cancer cells in s phase by targeting CBX4. Onco Targets Ther. 12:10535–10545. 2019.PubMed/NCBI View Article : Google Scholar
15	Rodriguez LG, Wu X and Guan JL: Wound-healing assay. Methods Mol Biol. 294:23–29. 2005.PubMed/NCBI View Article : Google Scholar
16	Das PK, Siddika MA, Asha SY, Aktar S, Rakib MA, Khanam JA, Pillai S and Islam F: MicroRNAs, a promising target for breast cancer stem cells. Mol Diagn Ther. 24:69–83. 2020.PubMed/NCBI View Article : Google Scholar
17	Cuk K, Zucknick M, Heil J, Madhavan D, Schott S, Turchinovich A, Arlt D, Rath M, Sohn C, Benner A, et al: Circulating microRNAs in plasma as early detection markers for breast cancer. Int J Cancer. 132:1602–1612. 2013.PubMed/NCBI View Article : Google Scholar
18	Bahrami A, Aledavood A, Anvari K, Hassanian SM, Maftouh M, Yaghobzade A, Salarzaee O, ShahidSales S and Avan A: The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs. J Cell Physiol. 233:774–786. 2018.PubMed/NCBI View Article : Google Scholar
19	Hafez MM, Hassan ZK, Zekri AR, Gaber AA, Al Rejaie SS, Sayed-Ahmed MM and Al Shabanah O: MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. Asian Pac J Cancer Prev. 13:591–598. 2012.PubMed/NCBI View Article : Google Scholar
20	Ai H, Zhou W, Wang Z, Qiong G, Chen Z and Deng S: microRNAs-107 inhibited autophagy, proliferation, and migration of breast cancer cells by targeting HMGB1. J Cell Biochem: Dec 2, 2018 (Epub ahead of print). doi: 10.1002/jcb.28157.
21	Wang D, Liu K and Chen E: LINC00511 promotes proliferation and invasion by sponging miR-515-5p in gastric cancer. Cell Mol Biol Lett. 25(4)2020.PubMed/NCBI View Article : Google Scholar
22	Pardo OE, Castellano L, Munro CE, Hu Y, Mauri F, Krell J, Lara R, Pinho FG, Choudhury T, Frampton AE, et al: miR-515-5p controls cancer cell migration through MARK4 regulation. EMBO Rep. 17:570–584. 2016.PubMed/NCBI View Article : Google Scholar
23	Pinho FG, Frampton AE, Nunes J, Krell J, Alshaker H, Jacob J, Pellegrino L, Roca-Alonso L, de Giorgio A, Harding V, et al: Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation. Cancer Res. 73:5936–5948. 2013.PubMed/NCBI View Article : Google Scholar
24	Ismail IH, Gagné JP, Caron MC, McDonald D, Xu Z, Masson JY, Poirier GG and Hendzel MJ: CBX4-mediated SUMO modification regulates BMI1 recruitment at sites of DNA damage. Nucleic Acids Res. 40:5497–5510. 2012.PubMed/NCBI View Article : Google Scholar
25	Hu C, Zhang Q, Tang Q, Zhou H, Liu W, Huang J, Liu Y, Wang Q, Zhang J, Zhou M, et al: CBX4 promotes the proliferation and metastasis via regulating BMI-1 in lung cancer. J Cell Mol Med. 24:618–631. 2020.PubMed/NCBI View Article : Google Scholar
26	Tan C, Bei C, Zhu X, Zhang Y, Qin L and Tan S: Single nucleotide polymorphisms of CBX4 and CBX7 decrease the risk of hepatocellular carcinoma. Biomed Res Int. 2019(6436825)2019.PubMed/NCBI View Article : Google Scholar
27	Meng R, Fang J, Yu Y, Hou LK, Chi JR, Chen AX, Zhao Y and Cao XC: miR-129-5p suppresses breast cancer proliferation by targeting CBX4. Neoplasma. 65:572–578. 2018.PubMed/NCBI View Article : Google Scholar
28	Chen Q, Huang L, Pan D, Zhu LJ and Wang YX: Cbx4 sumoylates Prdm16 to regulate adipose tissue thermogenesis. Cell Rep. 22:2860–2872. 2018.PubMed/NCBI View Article : Google Scholar
29	Li B, Zhou J, Liu P, Hu J, Jin H, Shimono Y, Takahashi M and Xu G: Polycomb protein Cbx4 promotes SUMO modification of de novo DNA methyltransferase Dnmt3a. Biochem J. 405:369–378. 2007.PubMed/NCBI View Article : Google Scholar
30	Li J, Xu Y, Long XD, Wang W, Jiao HK, Mei Z, Yin QQ, Ma LN, Zhou AW, Wang LS, et al: Cbx4 governs HIF-1α to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity. Cancer Cell. 25:118–131. 2014.PubMed/NCBI View Article : Google Scholar